Holen Sie sich die Stockscreener-App
3.205
1.75%
0.055
Finanzdaten der Jasper Therapeutics Inc-Aktie (JSPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
-0.118 | 0.051 | -0.109 | -0.07 |
Operating Expenses
|
14.97%
15.07
|
17.73 | 19.36 | 17.83 | 13.95 |
| Depreciation and Amortization |
0.288
|
- | - | 0.275 | 0.274 |
| Operating Income/Loss |
14.97%
-15.07
|
-17.73 | -19.36 | -17.83 | -13.95 |
| Nonoperating Income/Loss |
1.344
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
11,534%
-13.73
|
-0.118 | 0.051 | -16.08 | -14.26 |
| Income/Loss From Continuing Operations After Tax |
17.21%
-13.73
|
-16.58 | -17.54 | -16.08 | -14.26 |
|
Net Income/Loss
|
17.21%
-13.73
|
-16.58 | -17.54 | 16.10 | -14.26 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
114.51%
13.33
|
-91.91 | 109.72 | 109.21 | 88.16 |
| Diluted Average Shares |
114.51%
13.33
|
-91.91 | 109.72 | 109.21 | 88.16 |
| Basic Earnings Per Share |
81.96%
-1.03
|
-5.71 | -0.16 | -0.15 | -0.16 |
| Diluted Earnings Per Share |
81.96%
-1.03
|
-5.71 | -0.16 | -0.15 | -0.16 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
4.55%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):